Use of ß-blockers and mortality following ovarian cancer diagnosis: A population-based cohort study

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Johannesdottir, Sigrun A ^a,b   Schmidt, Morten ^a,b   Phillips, Gary ^a   Glaser, Ronald ^a,c,d   Yang, Eric V ^a,d   Blumenfeld, Michael ^c   Lemeshow, Stanley ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; SURVIVAL RATE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; YOUNG ADULT;

EID: 84874048411     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-85     Document Type: Article

References (28)

1. Ong HT. Beta blockers in hypertension and cardiovascular disease. BMJ 2007, 334:946-949. 10.1136/bmj.39185.440382.47, 1865458, 17478848.
2. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 2003, 9(9):4514-4521.
3. Lutgendorf SK, Johnsen EL, Cooper B, Anderson B, Sorosky JI, Buller RE, Sood AK. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 2002, 95:808-815. 10.1002/cncr.10739, 12209725.
4. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006, 12:369-375. 10.1158/1078-0432.CCR-05-1698, 3141061, 16428474.
5. Roy R, Zhang B, Moses MA. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 2006, 312:608-622. 10.1016/j.yexcr.2005.11.022, 16442099.
6. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005, 65:550-563. 10.1016/j.cardiores.2004.12.002, 15664381.
7. Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Yasasever V, Topuz E. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol 2005, 22:241-246. 10.1385/MO:22:3:241, 16110135.
8. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001, 19:577-583.
9. Lemeshow S, Sorensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R. ß-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 2011, 20:2273-2279. 10.1158/1055-9965.EPI-11-0249, 21933972.
10. Diaz ES, Karlan BY, Li AJ. Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol 2012, 127:375-378. 10.1016/j.ygyno.2012.07.102, 22819786.
11. Danish Medicines Agency Information on over-the-counter medicine and reimbursement criteria in Denmark Available from URL: http://laegemiddelstyrelsen.dk/en/ [accessed August 22, 2012], Danish Medicines Agency.
12. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010, 2:273-279. 2998817, 21152254.
13. Pedersen CB. The Danish civil registration system. Scand J Public Health 2011, 39:22-25. 10.1177/1403494810387965, 21775345.
14. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011, 39:42-45. 10.1177/1403494810393562, 21775350.
15. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008, 167:492-499. 10.1093/aje/kwm324, 18056625.
16. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011, 39:30-33. 10.1177/1403494811401482, 21775347.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
18. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005, 20:12-19. 10.1016/j.jcrc.2004.09.007, 16015512.
19. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011, 11:83. 10.1186/1471-2288-11-83, 3125388, 21619668.
20. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005, 28:759-762. 10.1016/j.ejcts.2005.06.046, 16157485.
21. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997, 107:1469-1475. 10.1097/00005537-199711000-00009, 9369392.
22. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 1989, 86:9524-9528. 10.1073/pnas.86.23.9524, 298529, 2556716.
23. Yang EV, Donovan EL, Benson DM, Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun 2008, 22:318-323. 10.1016/j.bbi.2007.09.010, 2259392, 17981009.
24. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009, 23:267-275. 10.1016/j.bbi.2008.10.005, 2652747, 18996182.
25. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006, 66:10357-10364. 10.1158/0008-5472.CAN-06-2496, 17079456.
26. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 2011, 12:65-82. 10.1016/S1470-2045(10)70260-6, 21123111.
27. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988, 17:44-49. 10.1093/ije/17.1.44, 3384548.
28. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997, 44:535-539.